Literature DB >> 26144316

The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1.

Wilhelm Palm1, Youngkyu Park2, Kevin Wright2, Natalya N Pavlova1, David A Tuveson2, Craig B Thompson3.   

Abstract

Despite being surrounded by diverse nutrients, mammalian cells preferentially metabolize glucose and free amino acids. Recently, Ras-induced macropinocytosis of extracellular proteins was shown to reduce a transformed cell's dependence on extracellular glutamine. Here, we demonstrate that protein macropinocytosis can also serve as an essential amino acid source. Lysosomal degradation of extracellular proteins can sustain cell survival and induce activation of mTORC1 but fails to elicit significant cell accumulation. Unlike its growth-promoting activity under amino-acid-replete conditions, we discovered that mTORC1 activation suppresses proliferation when cells rely on extracellular proteins as an amino acid source. Inhibiting mTORC1 results in increased catabolism of endocytosed proteins and enhances cell proliferation during nutrient-depleted conditions in vitro and within vascularly compromised tumors in vivo. Thus, by preventing nutritional consumption of extracellular proteins, mTORC1 couples growth to availability of free amino acids. These results may have important implications for the use of mTOR inhibitors as therapeutics.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26144316      PMCID: PMC4506698          DOI: 10.1016/j.cell.2015.06.017

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  29 in total

1.  Bidirectional transport of amino acids regulates mTOR and autophagy.

Authors:  Paul Nicklin; Philip Bergman; Bailin Zhang; Ellen Triantafellow; Henry Wang; Beat Nyfeler; Haidi Yang; Marc Hild; Charles Kung; Christopher Wilson; Vic E Myer; Jeffrey P MacKeigan; Jeffrey A Porter; Y Karen Wang; Lewis C Cantley; Peter M Finan; Leon O Murphy
Journal:  Cell       Date:  2009-02-06       Impact factor: 41.582

Review 2.  Virus entry by macropinocytosis.

Authors:  Jason Mercer; Ari Helenius
Journal:  Nat Cell Biol       Date:  2009-05       Impact factor: 28.824

3.  Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids.

Authors:  Yasemin Sancak; Liron Bar-Peled; Roberto Zoncu; Andrew L Markhard; Shigeyuki Nada; David M Sabatini
Journal:  Cell       Date:  2010-04-08       Impact factor: 41.582

4.  Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells.

Authors:  Jihye Yun; Carlo Rago; Ian Cheong; Ray Pagliarini; Philipp Angenendt; Harith Rajagopalan; Kerstin Schmidt; James K V Willson; Sandy Markowitz; Shibin Zhou; Luis A Diaz; Victor E Velculescu; Christoph Lengauer; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Science       Date:  2009-08-06       Impact factor: 47.728

5.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

Authors:  Sunil R Hingorani; Lifu Wang; Asha S Multani; Chelsea Combs; Therese B Deramaudt; Ralph H Hruban; Anil K Rustgi; Sandy Chang; David A Tuveson
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

Review 6.  The role of the Atg1/ULK1 complex in autophagy regulation.

Authors:  Noboru Mizushima
Journal:  Curr Opin Cell Biol       Date:  2010-01-06       Impact factor: 8.382

Review 7.  Regulation mechanisms and signaling pathways of autophagy.

Authors:  Congcong He; Daniel J Klionsky
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

Review 8.  Molecular mechanisms of mTOR-mediated translational control.

Authors:  Xiaoju Max Ma; John Blenis
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04-02       Impact factor: 94.444

Review 9.  AKT/PKB signaling: navigating downstream.

Authors:  Brendan D Manning; Lewis C Cantley
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

10.  Regulation of TORC1 by Rag GTPases in nutrient response.

Authors:  Eunjung Kim; Pankuri Goraksha-Hicks; Li Li; Thomas P Neufeld; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2008-07-06       Impact factor: 28.824

View more
  188 in total

1.  mTORC1 maintains metabolic balance.

Authors:  Heesun Cheong; Daniel J Klionsky
Journal:  Cell Res       Date:  2015-09-11       Impact factor: 25.617

2.  The breadth of macropinocytosis research.

Authors:  Joel A Swanson; Jason S King
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-04       Impact factor: 6.237

3.  Gold/alpha-lactalbumin nanoprobes for the imaging and treatment of breast cancer.

Authors:  Jiang Yang; Tai Wang; Lina Zhao; Vinagolu K Rajasekhar; Suhasini Joshi; Chrysafis Andreou; Suchetan Pal; Hsiao-Ting Hsu; Hanwen Zhang; Ivan J Cohen; Ruimin Huang; Ronald C Hendrickson; Matthew M Miele; Wenbo Pei; Matthew B Brendel; John H Healey; Gabriela Chiosis; Moritz F Kircher
Journal:  Nat Biomed Eng       Date:  2020-07-13       Impact factor: 25.671

4.  Dynamin-dependent amino acid endocytosis activates mechanistic target of rapamycin complex 1 (mTORC1).

Authors:  Shusaku Shibutani; Hana Okazaki; Hiroyuki Iwata
Journal:  J Biol Chem       Date:  2017-08-14       Impact factor: 5.157

5.  CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages.

Authors:  Regina Pacitto; Isabella Gaeta; Joel A Swanson; Sei Yoshida
Journal:  J Leukoc Biol       Date:  2016-10-17       Impact factor: 4.962

Review 6.  Lymphangioleiomyomatosis: A Monogenic Model of Malignancy.

Authors:  Vera P Krymskaya; Francis X McCormack
Journal:  Annu Rev Med       Date:  2017-01-14       Impact factor: 13.739

7.  Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways.

Authors:  Seong M Kim; Saurabh G Roy; Bin Chen; Tiffany M Nguyen; Ryan J McMonigle; Alison N McCracken; Yanling Zhang; Satoshi Kofuji; Jue Hou; Elizabeth Selwan; Brendan T Finicle; Tricia T Nguyen; Archna Ravi; Manuel U Ramirez; Tim Wiher; Garret G Guenther; Mari Kono; Atsuo T Sasaki; Lois S Weisman; Eric O Potma; Bruce J Tromberg; Robert A Edwards; Stephen Hanessian; Aimee L Edinger
Journal:  J Clin Invest       Date:  2016-09-26       Impact factor: 14.808

8.  mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer.

Authors:  David R Driscoll; Saadia A Karim; Makoto Sano; David M Gay; Wright Jacob; Jun Yu; Yusuke Mizukami; Aarthi Gopinathan; Duncan I Jodrell; T R Jeffry Evans; Nabeel Bardeesy; Michael N Hall; Brian J Quattrochi; David S Klimstra; Simon T Barry; Owen J Sansom; Brian C Lewis; Jennifer P Morton
Journal:  Cancer Res       Date:  2016-10-06       Impact factor: 12.701

9.  PIKfyve Regulates Vacuole Maturation and Nutrient Recovery following Engulfment.

Authors:  Shefali Krishna; Wilhelm Palm; Yongchan Lee; Wendy Yang; Urmi Bandyopadhyay; Haoxing Xu; Oliver Florey; Craig B Thompson; Michael Overholtzer
Journal:  Dev Cell       Date:  2016-09-12       Impact factor: 12.270

10.  The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.

Authors:  Carsten Gram Hansen; Yuen Lam Dora Ng; Wai-Ling Macrina Lam; Steven W Plouffe; Kun-Liang Guan
Journal:  Cell Res       Date:  2015-11-27       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.